 |
|
Comparison Between Adult Endocarditis Due to  -Hemolytic Streptococci (Serogroups A, B, C, and G) and Streptococcus milleri
A Multicenter Study in France
Agnès Lefort, MD;
Olivier Lortholary, MD, PhD;
Philippe Casassus, MD;
Christine Selton-Suty, MD;
Loïc Guillevin, MD;
Jean-Luc Mainardi, MD, PhD;
for the  -Hemolytic Streptococci Infective Endocarditis Study Group
Arch Intern Med. 2002;162:2450-2456.
Background Limited data exist on infective endocarditis (IE) due to Streptococcus milleri (Sm) or -hemolytic streptococci (BHS). Because BHS and Sm share some physiologic and pathogenic properties, we wondered whether IE caused by these streptococci might present similarities.
Methods Through a nationwide retrospective study in France, the medical and microbiologic charts of adults with definite Sm or BHS IE observed between January 1, 1991, and December 31, 1996, in university and general hospitals were reviewed.
Results Fifty-six patients had BHS IE (33 men and 23 women; median age, 59 years; range, 18-91 years) and 29 had Sm IE (18 men and 11 women; median age, 66 years; range, 37-97 years). The BHS group tended to have more underlying medical conditions (46%) and fewer previous cardiopathies (48%) than the Sm group (28% and 71%, respectively). Multivariate analysis showed that a longer median time of IE evolution before diagnosis and identification of the presumed portal of entry were independently associated with Sm IE (P<.01). Extracardiac complications were more frequent in the BHS group (55%) than in the Sm group (39%). Comparison of echocardiographic findings between the 2 groups did not establish any statistically significant difference. Thirty-six patients (64%) in the BHS group and 18 (62%) in the Sm group underwent valve replacement. Overall, mortality was 27% for the BHS group and 14% for the Sm group. For all patients, multivariate analysis retained older age as the only significant risk factor for death (P = .01).
Conclusion Compared with Sm IE, BHS IE occurs in younger patients with more underlying diseases and fewer underlying cardiopathies and has a more aggressive presentation and evolution.
From Fédération de Médecine Interne, Maladies Infectieuses et Tropicales, Hôpital Avicenne, Université Paris-Nord, Bobigny, France (Drs Lefort, Lortholary, Casassus, and Guillevin); Service de Cardiologie, Hôpital Brabois, Vandoeuvre, France (Dr Selton-Suty); Association pour l'Étude et la Prévention de l'Endocardite Infectieuse, Hôpital Bichat, Paris, France (Drs Lortholary, Selton-Suty, and Mainardi); Unité Mobile de Microbiologie Clinique, Service de Microbiologie Clinique, Hôpital Européen Georges-Pompidou, Paris (Dr Mainardi). Dr Lefort is now with the Service de Médecine Interne, Hôpital Beaujon, Clichy, France.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Infective Endocarditis Associated With a Scorpion Sting
Wheatley et al.
Ann. Thorac. Surg. 2005;80:1489-1490.
ABSTRACT
| FULL TEXT
Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Baddour et al.
Circulation 2005;111:e394-e434.
ABSTRACT
| FULL TEXT
Culture results of heart valves resected because of streptococcal endocarditis: insights into duration of treatment to achieve valve sterilization
Upton et al.
J Antimicrob Chemother 2005;55:234-239.
ABSTRACT
| FULL TEXT
Case 29-2004 - A 75-Year-Old Woman with Acute Onset of Chest Pain Followed by Fever
Karchmer et al.
NEJM 2004;351:1240-1248.
FULL TEXT
|
